ロード中...
Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility
Immune evasion is a critical mechanism of malignant cell survival, and relies in part on molecular signaling through the programmed cell death 1 (PD-1)/PD-1 ligand (PD-L1) axis that contributes to T cell exhaustion. Immune modulatory therapy with monoclonal antibodies against PD-1 designed to enhanc...
保存先:
| 出版年: | Ther Adv Hematol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5881987/ https://ncbi.nlm.nih.gov/pubmed/29623180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718761777 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|